Effects of a Flipped-Learning Empowering Leadership Program on Nurse Leaders, Staff, and Residents in Long-Term Care Facilities
17 de agosto de 2026 actualizado por: I-Hui-Chen
Flipped Learning for Leader Empowering Leadership in Aged Care: A Pilot Cluster Quasi-Experimental Study
This pilot cluster quasi-experimental study tested a 12-week empowering-leadership training program delivered through flipped learning to nurse leaders in residential long-term care facilities, compared with a conventional brochure-based approach.
Six facilities in central Taiwan participated: two (one public, one private) received the flipped-learning program for their leaders, and four (one public, three private) served as controls.
The study examined effects at three levels: nurse leaders' own empowering leadership behaviors and facility-level nursing staff retention/turnover and resident hospitalization rates; nursing staff's perceptions of their leader's empowering behaviors, burnout, psychological empowerment, and job satisfaction; and residents' health status, quality of life, and satisfaction with care.
Descripción general del estudio
Estado
Terminado
Condiciones
Tipo de estudio
Intervencionista
Inscripción (Actual)
287
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Taichung, Taiwán
- Residential Long-Term Care Facilities
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
Nurse Leaders:
- Age ≥ 20 years
- Employed as nursing director, supervisor, or head
- Employed at the facility for more than 6 months
- Willing to participate and able to give informed consent
Nursing Staff:
- Registered nurse, licensed practical nurse, or nursing assistant
- Employed at the facility for ≥ 3 months
- Age ≥ 20 years
- Informed consent given
Residents:
- Resided at the facility for ≥ 3 months
- Mini-Mental State Examination (MMSE) score ≥ 24
- No severe hearing impairment
- Not terminally ill
- Written informed consent given (or via authorized representative as applicable)
Exclusion Criteria:
Nurse Leaders:
- Indicated intent to leave the position within the next 6 months
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Flipped Learning Intervention
2 residential long-term care facilities (1 public, 1 private): 10 nurse leaders, 40 nursing staff, 100 residents.
Nurse leaders received a 12-week flipped-learning empowering leadership program.
|
A 12-week, 24-hour empowering leadership program (one 2-hour module per week).
Each week, a 60-minute instructional video was posted for asynchronous pre-class learning, followed by a 1-hour face-to-face session (small-group discussion, case studies, brief presentations, practical exercises), with instructor summary.
Post-class activities included reflection and assignments.
|
|
Comparador activo: Conventional Learning / Control
4 residential long-term care facilities (1 public, 3 private): 11 nurse leaders, 40 nursing staff, 86 residents.
Nurse leaders received a printed brochure with identical content, without structured flipped-learning sessions.
|
Nurse leaders in the control group received a printed brochure covering the same empowerment/empowering-behavior content as the intervention group, without structured flipped-learning sessions.
The research team maintained regular contact to answer questions but provided no additional training.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Leader Empowerment Behavior
Periodo de tiempo: Baseline and immediately post-intervention (approximately 12 weeks)
|
Leader Empowerment Behavior Scale (Chinese version), a 27-item self-report measure across 5 subscales (extending meaning of work, engaging staff in decision-making, expressing confidence, encouraging goal achievement, providing autonomy).
Each item rated on a 7-point Likert scale (1=strongly disagree, 7=strongly agree); total score range 27-189, with higher scores indicating more empowering leadership behavior (better outcome).
Cronbach's α=0.71; test-retest r=0.83.
|
Baseline and immediately post-intervention (approximately 12 weeks)
|
|
Staff-Perceived Leader Empowering Behavior
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Modified version of the Leader Empowerment Behavior Scale, a 27-item measure completed by nursing staff about their leader, across 5 subscales.
Each item rated on a 7-point Likert scale; total score range 27-189, with higher scores indicating more empowering behavior as perceived by staff (better outcome).
Cronbach's α=0.85; test-retest r=0.71.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Occupational Burnout
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Occupational Burnout Inventory Scale, a 21-item self-report measure across 4 subscales (personal burnout, work-related burnout, client-related burnout, over-commitment to work).
Each item rated on a 5-point Likert scale; total score range 21-105, with higher scores indicating greater burnout (worse outcome).
Cronbach's α=0.80; test-retest reliability=0.78.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Psychological Empowerment
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Spreitzer's Psychological Empowerment Scale, a 12-item self-report measure across 4 subscales (meaning, competence, self-determination, impact).
Each item rated on a 5-point Likert scale; total score range 12-60, with higher scores indicating greater psychological empowerment (better outcome).
Cronbach's α=0.87; test-retest reliability=0.82.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Job Satisfaction
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Minnesota Satisfaction Questionnaire Short Form, a 20-item self-report measure.
Each item rated on a 5-point Likert scale; total score range 20-100, with higher scores indicating greater job satisfaction (better outcome).
Cronbach's α=0.88; test-retest reliability=0.84.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Job Stress
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Single-item self-report measure ("Do you often feel very stressed at work?"), rated on a 5-point Likert scale; score range 1-5, with higher scores indicating greater job stress (worse outcome).
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Health Status (SF-36)
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
36-Item Short Form Health Survey (SF-36), across 8 domains (physical functioning, role limitations due to physical health, role limitations due to emotional problems, pain, emotional well-being, social functioning, energy, general health).
Each domain scored 0-100, with higher scores indicating better health status (better outcome).
Cronbach's α=0.78-0.90;
test-retest reliability=0.86-0.91.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Quality of Life (WHOQOL-BREF)
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
World Health Organization Quality of Life Questionnaire, Abbreviated Version (WHOQOL-BREF), across 4 domains (physical health, psychological health, social relationships, environmental health).
Domain scores range from 4 to 20, with higher scores indicating better quality of life (better outcome).
Cronbach's α=0.80-0.88;
test-retest reliability=0.90-0.95.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Care Quality / Customer Satisfaction
Periodo de tiempo: Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
Customer Satisfaction Scale, a 25-item self-report measure across 4 subscales (comfort/cleanliness, nursing care, food services, facility care/services).
Each item rated on a 5-point Likert scale; total score range 25-125, with higher scores indicating greater satisfaction with care quality (better outcome).
Cronbach's α=0.94; test-retest reliability=0.75.
|
Baseline (at enrollment) and 3 months after intervention completion (approximately August 2019)
|
|
Nursing Staff Retention Rate
Periodo de tiempo: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
|
|
Nursing Staff Turnover Rate
Periodo de tiempo: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
|
|
Resident Hospitalization Rate
Periodo de tiempo: 12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
12-month period prior to the intervention (baseline) and 12-month period beginning approximately 1 month after the 12-week intervention was completed (follow-up)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de agosto de 2018
Finalización primaria (Actual)
30 de mayo de 2019
Finalización del estudio (Actual)
30 de mayo de 2020
Fechas de registro del estudio
Enviado por primera vez
13 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
17 de agosto de 2026
Publicado por primera vez (Actual)
19 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
19 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
17 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- CRREC-105-002
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .